GB9405856D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
GB9405856D0
GB9405856D0 GB9405856A GB9405856A GB9405856D0 GB 9405856 D0 GB9405856 D0 GB 9405856D0 GB 9405856 A GB9405856 A GB 9405856A GB 9405856 A GB9405856 A GB 9405856A GB 9405856 D0 GB9405856 D0 GB 9405856D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9405856A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB9405856A priority Critical patent/GB9405856D0/en
Publication of GB9405856D0 publication Critical patent/GB9405856D0/en
Priority to PCT/EP1995/001039 priority patent/WO1995025516A1/en
Priority to JP7524382A priority patent/JPH09510470A/en
Priority to EP95928859A priority patent/EP0751771A1/en
Pending legal-status Critical Current

Links

GB9405856A 1994-03-24 1994-03-24 Pharmaceutical formulation Pending GB9405856D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB9405856A GB9405856D0 (en) 1994-03-24 1994-03-24 Pharmaceutical formulation
PCT/EP1995/001039 WO1995025516A1 (en) 1994-03-24 1995-03-20 Pharmaceutical formulations containing beta-lactam antibiotics and an alkyl sulphate surfactant
JP7524382A JPH09510470A (en) 1994-03-24 1995-03-20 Pharmaceutical formulations containing beta-lactam antibiotics and alkyl sulphate surfactants
EP95928859A EP0751771A1 (en) 1994-03-24 1995-03-20 Pharmaceutical formulations containing beta-lactam antibiotics and an alkyl sulphate surfactant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9405856A GB9405856D0 (en) 1994-03-24 1994-03-24 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
GB9405856D0 true GB9405856D0 (en) 1994-05-11

Family

ID=10752439

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9405856A Pending GB9405856D0 (en) 1994-03-24 1994-03-24 Pharmaceutical formulation

Country Status (4)

Country Link
EP (1) EP0751771A1 (en)
JP (1) JPH09510470A (en)
GB (1) GB9405856D0 (en)
WO (1) WO1995025516A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR004510A1 (en) 1995-09-07 1998-12-16 Smithkline Beecham Plc COMPOSITIONS INCLUDING AMOXICILLIN AND CLAVULANATE, PROCEDURES FOR ITS PREPARATION AND THE USE OF COMPOSITIONS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
DE69815833T2 (en) * 1997-02-14 2004-05-19 Laboratoire Glaxosmithkline S.A.S. MEDICAL PREPARATIONS CONTAINING AMOXICILLIN AND CLAVULANATE
SE9700885D0 (en) * 1997-03-12 1997-03-12 Astra Ab New pharmaceutical formulation
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
GB9930578D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Pharmaceutical formulations
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AU2002315287A1 (en) * 2001-04-12 2002-10-28 Sandoz Gmbh Pharmaceutical composition comprising clavulanic acid
AT413983B (en) * 2001-04-12 2006-08-15 Sandoz Ag Pharmaceutical composition useful for reducing rapid degradation of the active ingredient comprises clavulanate, in the form of granulated and hydrophobised particles, and an active ingredient
AT412344B (en) * 2001-04-12 2005-01-25 Sandoz Ag Pharmaceutical composition useful for reducing rapid degradation of the active ingredient comprises clavulanate, in the form of granulated and hydrophobised particles, and an active ingredient
CA2459014C (en) * 2001-09-14 2010-08-10 Scolr, Inc. Amino acid modulated extended release dosage form
WO2006072577A1 (en) * 2005-01-07 2006-07-13 Sandoz Ag Process for preparing granulates comprising amoxicillin
AU2008317315A1 (en) * 2007-10-26 2009-04-30 Rexahn Pharmaceuticals, Inc. Pharmaceutical formulation of clavulanic acid
CN112587481B (en) * 2020-12-28 2022-03-15 成都中牧生物药业有限公司 Alkalescent amoxicillin soluble powder and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2523446A1 (en) * 1982-03-19 1983-09-23 Dietlin Francois Controlled release pharmaceutical compsns. - for oral admin. contg. konjak mannan(s) and surfactant
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
WO1988009173A1 (en) * 1987-05-27 1988-12-01 Akzo N.V. DRY, RAPIDLY SOLUBLE, COMPOSITIONS OF beta-LACTAM ANTIBIOTICS
NZ234587A (en) * 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
GB9009473D0 (en) * 1990-04-27 1990-06-20 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
EP0751771A1 (en) 1997-01-08
JPH09510470A (en) 1997-10-21
WO1995025516A1 (en) 1995-09-28

Similar Documents

Publication Publication Date Title
GB9407386D0 (en) Pharmaceutical formulation
GB9402203D0 (en) Pharmaceutical formulation
IL112521A0 (en) Pharmaceutical formulation
ZA953236B (en) Pharmaceutical formulations
GB9519363D0 (en) Pharmaceutical formulation
ZA951781B (en) Pharmaceutical formulations
EP0862431A4 (en) Pharmaceutical formulation
GB9405856D0 (en) Pharmaceutical formulation
GB9416599D0 (en) Pharmaceutical formulation
GB9523566D0 (en) Pharmaceutical formulation
GB9408053D0 (en) Pharmaceutical preparation
ZA96526B (en) Novel pharmaceutical formulation
GB9709739D0 (en) Pharmaceutical formulation
GB9418550D0 (en) Drug formulation
GB9413542D0 (en) Pharmaceutical formulations
GB9425074D0 (en) Pharmaceutical formulation
GB9425075D0 (en) Pharmaceutical formulation
GB9412395D0 (en) Pharmaceutical formulation
ZA952013B (en) Pharmaceutical preparation
GB9603141D0 (en) Pharmaceutical formulation
GB9426113D0 (en) Pharmaceutical formulations
GB9408162D0 (en) Pharmaceutical formulations
GB9408151D0 (en) Pharmaceutical formulations
GB9401738D0 (en) Pharmaceutical formulations
GB9408163D0 (en) Pharmaceutical formulations